Allan R. Brasier

发表

Angiotensinogen gene-inducible enhancer-binding protein 1, a member of a new family of large nuclear proteins that recognize nuclear factor kappa B-binding sites through a zinc finger motif

D. Ron, A. Brasier, J. Habener, 1991, Molecular and cellular biology.

Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines.

A. Brasier, J. Habener, J F Habener, 1989, BioTechniques.

Mechanisms for inducible control of angiotensinogen gene transcription.

A. Brasier, J. Li, Junyi Li, 1996, Hypertension.

Transcriptional regulation of angiotensinogen gene expression.

A. Brasier, Youqi Han, Y. Han, 1999, Vitamins and hormones.

Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes.

A. Brasier, J. Li, Junyi Li, 1996, Molecular endocrinology.

Role of signal transducers and activators of transcription 1 and -3 in inducible regulation of the human angiotensinogen gene by interleukin-6.

A. Brasier, C. T. Sherman, Allan R. Brasier, 2001, Molecular endocrinology.

Differentiation-specific element: a cis-acting developmental switch required for the sustained transcriptional expression of the angiotensinogen gene during hormonal-induced differentiation of 3T3-L1 fibroblasts to adipocytes.

D. Ron, A. Brasier, J. Habener, 1993, Molecular endocrinology.

A family of constitutive C/EBP‐like DNA binding proteins attenuate the IL‐1 alpha induced, NF kappa B mediated trans‐activation of the angiotensinogen gene acute‐phase response element.

D. Ron, A. Brasier, J. Habener, 1990, The EMBO journal.